Structure Info
- Chemspace ID
- CSSS00159257600 (In-Stock Screening Compounds)
- MFCD
- MFCD08063732, MFCD32662393
- IUPAC Name
- (2S,3R,4S,5S,6R)-2-{4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
- Mol formula
- C20H22O8
- Mol weight
- 390 Da
- Catalog Number(s)
- A1144466, AA00C9PW, AF72368, AG00C9SO, AR00CAHO, ArZ-UP483137, BD01105954, BICL2523, CFN93239, CSC159257600, G17175, HY-N4195, JH284539, MR10469, MS-26498, NP-004019, R150085, TN2144, Y3292960, ZX-CY004913, ZXC368240
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.13
- Heavy atoms count
- 28
- Rotatable bond count
- 5
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.3
- Polar surface area (Å)
- 140
- Hydrogen bond acceptors count
- 8
- Hydrogen bond donors count
- 6
- Zoom the structure
- CSSS00159257600
Items Overall 18 items from 5 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 10 days | United States To: | 99 | 1 mg | 90 | |
MedChemExpress | 10 days | United States To: | 99 | 5 mg | 250 | |
Description: Names: Resveratroloside; Resveratrol glycoside; trans-Resveratrol 4'-O-β-D-glucopyranoside; Product Description: Resveratroloside (Resveratrol glycoside) is a competitive inhibitior of α-glucosidase with an IC 50 of 22.9 μM. Resveratroloside has the ability to regulate PBG (postprandial blood glucose) levels. Resveratroloside exhibits cardioprotective effect .; Target: Glycosidase; CAS: 38963-95-0 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 99 | 1 mg | 95 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 263 | |
Description: Names: Resveratroloside; Resveratrol glycoside; trans-Resveratrol 4'-O-β-D-glucopyranoside; Product Description: Resveratroloside (Resveratrol glycoside) is a competitive inhibitior of α-glucosidase with an IC50 of 22.9 μM. Resveratroloside has the ability to regulate PBG (postprandial blood glucose) levels. Resveratroloside exhibits cardioprotective effect; Target: Glycosidase; CAS: 38963-95-0 | ||||||
ChemFaces | 12 days | China To: | 90 | 1 mg | 68 | |
AnalytiCon Discovery GmbH | 15 days | Germany To: | 90 | 1 mg | 340 | |
AnalytiCon Discovery GmbH | 15 days | Germany To: | 90 | 2 mg | 426 | |
AnalytiCon Discovery GmbH | 15 days | Germany To: | 90 | 5 mg | 682 | |
AnalytiCon Discovery GmbH | 15 days | Germany To: | 90 | 10 mg | 1,111 | |
AnalytiCon Discovery GmbH | 15 days | Germany To: | 90 | 20 mg | 1,784 | |
AnalytiCon Discovery GmbH | 15 days | Germany To: | 90 | 25 mg | 2,093 | |
AnalytiCon Discovery GmbH | 15 days | Germany To: | 90 | 50 mg | 3,544 | |
AnalytiCon Discovery GmbH | 15 days | Germany To: | 90 | 100 mg | 7,084 | |
Description: CAS: 38963-95-0 | ||||||
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 1 mg | 90 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 5 mg | 215 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 10 mg | 318 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 25 mg | 536 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 50 mg | 773 | |
Description: Resveratroloside has cardioprotective effect, it exhibits α±-glucosidase inhibitory activity, it also can inhibit hydroxylation of testosterone by CYP3A4.; CAS: 38963-95-0 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire